Clinical and prognostic significance of baseline microRNA 223 in acute ischemic stroke

Table 2 Correlation between baseline mir-223 levels and clinical and laboratory data

	All patients		Patients with favorable outcome		Patients with unfavorable outcome
	r	p	r	p	r	p
Age	0.12	0.23	− 0.15	0.32	0.08	0.61
BMI	0.002	0.99	− 0.04	0.78	− 0.14	0.33
Infarct size	0.35	< 0.001	0.12	0.44	0.19	0.19
NIHSS	0.29	0.004	0.16	0.3	− 0.09	0.53
Hb	0.03	0.77	− 0.02	0.88	− 0.03	0.85
WBCs	− 0.02	0.88	− 0.01	0.93	− 0.05	0.72
Platelets	− 0.01	0.92	− 0.03	0.83	− 0.12	0.41
FBG	0.04	0.72	0.12	0.46	− 0.02	0.87
Cholesterol	0.23	0.03	0.36	0.017	0.001	0.99
Triglycerides	0.16	0.13	0.26	0.09	− 0.06	0.66
LDL	0.18	0.09	0.4	0.008	0.01	0.92
HDL	− 0.33	0.001	− 0.48	0.001	− 0.21	0.15
HbA1c	0.01	0.91	− 0.24	0.12	− 0.05	0.74
CRP	0.27	0.001	0.11	0.44	0.17	0.24
Uric acid	− 0.02	0.84	0.002	0.99	− 0.27	0.058
Urea	0.11	0.3	0.25	0.1	− 0.009	0.95
Creatinine	0.09	0.37	0.11	0.47	0.13	0.39

BMI: Body mass index, CRP: C-reactive protein, FBG: Fasting blood glucose, Hb: Hemoglobin, HDL: High-density lipoprotein, LDL: Low-density lipoprotein, NIHSS: National Institutes of Health Stroke Scale, WBCs: White blood cells